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Assessment of global cardiac I-123 MIBG
uptake and washout using volumetric
quantification of SPECT acquisitions
Berlinda J. van der Veen, MSc,a Imad Al Younis, MD,a Albert de Roos, MD, PhD,b
and Marcel P. M. Stokkel, MD, PhDc
Background. Assessment of cardiac innervation using single-photon emission computer
tomography (SPECT) is less established than planar imaging, but may be more suitable for
quantification. Therefore, a volumetric quantification of I-123 MIBG SPECT acquisitions was
performed. Reproducibility, the effects of extra cardiac I-123 MIBG uptake and the relation
with conventional planar indices were evaluated.
Methods. 54 patients referred for planar and SPECT I-123 MIBG acquisitions were
included. Ellipsoidal or box-shaped volumes of interest were placed on the left ventricle, cardiac
lumen, mediastinum, lung and liver. SPECT segmentation was performed twice in all patients.
Indices were determined based on the heart-to-mediastinum (HM), myocardial wall-to-medi-
astinum and myocardial wall-to-lumen regions. HM ratios and washout rates were also
determined based on anterior planar images.
Results. Cardiac count densities were highly reproducible (CV 1.5-5.4, ICC 0.96-0.99) and
inter-rater variability was low (CV 1.8-6.8, ICC 0.94-0.99). Mediastinal uptake was an
important explanatory variable of uptake in the entire heart (early R2 5 0.36; delayed R2
=0.43) and myocardial wall (early R2 5 0.28; delayed R2 5 0.37). Lung washout was an
explanatory variable of organ washout of the heart (heart R2 5 0.38; myocardial wall
R2 5 0.33). In general, SPECT indices showed moderate-to-good correlations with the planar
uptake (PCC 0.497-0.851).
Conclusion. By applying a volumetric segmentation method we were able to segment the
heart in all patients. SPECT I-123 MIBG quantification was found to be highly reproducible and
had a moderate to good correlation with the planar indices. (J Nucl Cardiol 2012;19:752–62.)
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INTRODUCTION
Innervation imaging with radioiodinated meta-iod-
obenzylguanidine (I-123 MIBG) is the most widely used
imaging technique to evaluate sympathetic nerve activ-
ity in cardiac diseases. The resemblance of MIBG to
norepinephrine with respect to the molecular structure,
synaptic uptake and intracellular storage makes it a
suitable tracer to study sympathetic nervous activity.1-4
In general, the in-vivo visualization of cardiac
innervation is evaluated on planar anterior images,
which are acquired early and 3 to 5 hours after tracer
injection. For quantification, myocardial and mediastinal
regions of interest (ROIs) are drawn on anterior planar
images, of which mediastinal ROI is thought to repre-
sent the non-specific I-123 MIBG uptake in soft tissue.5
Information on the distribution of neurons and function
of the (re-)uptake-1 pathway is provided by the heart-to-
mediastinum (HM) ratio, while the washout rate (WOR)
provides information on the sympathetic drive. Both
indices are commonly applied in I-123 MIBG imaging
From the Department of Nuclear Medicine,a and Radiology,b Leiden
University Medical Centre, Leiden, The Netherlands; and Depart-
ment of Nuclear Medicine,c Netherlands Cancer Institut—Antoni
van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Received for publication Oct 13, 2011; final revision accepted Feb 18,
2012.
Reprint requests: Berlinda J. van der Veen, MSc, Department of
Nuclear Medicine, Leiden University Medical Center, P.O. Box
9600, 2300 RC Leiden, The Netherlands; l.vd.veen@nki.nl.
1071-3581/$34.00




and the inter- and intraobserver variability of the HM
ratio are considered low.6,7
Though planar imaging is widely used, quantification
based on these acquisitions has important limitations.
Precise quantification of myocardial counts is often
complicated due to superimposition of adjacent organs
onto the cardiac region. Furthermore, planar images do
not contain three-dimensional information, making it
difficult to assess regional innervation abnormalities.8,9
Single-photon emission computer tomography (SPECT)
is known to overcome these problems. Still, the quanti-
fication of global cardiac innervation using SPECT is less
established than planar I-123 MIBG imaging.
At present, SPECT imaging is considered informa-
tive in diseases like ischaemic heart disease, ventricular
arrhythmias and diabetes mellitus were the cardiac
innervation is affected in a heterogeneous manner.9
Consequently, this technique is increasingly used to
assess the regional I-123 MIBG uptake.6,8,10-13 Using
SPECT, it is possible to distinguish between myocardial
wall, left ventricular lumen and surrounding organs. The
ability to precisely localize these organs may suggest
that SPECT acquisitions are also more suitable for the
quantification of global innervation. To explore this
hypothesis, we applied a simple volumetric quantifica-
tion method on cardiac I-123 MIBG SPECT
acquisitions. Global uptake in the heart, myocardial
wall, ventricular lumen and surrounding organs were
determined in clinical patient groups. Based on this data
we studied reproducibility of SPECT segmentation, the
effect of extra cardiac I-123 MIBG uptake and the




The included population consisted of patients
referred for I-123 MIBG acquisition prior to placement
of a (biventricular) cardiac device (ICD) (group ICD,
n = 28), to distinguish between neurodegenerative dis-
eases (group NDD, n = 11), or after radiotherapy-
chemotherapy (group RCT, n = 15). Since these groups
all contain clinical patients, none of them can be
considered a normal reference population. Still, the
selection of these three populations ensures the inclusion
of patients with a low cardiac I-123 MIBG uptake and a
relatively normal I-123 MIBG uptake. All patients were
referred for both planar and SPECT acquisitions in the
period from November 2008 to March 2011 as part of
their clinical work-up. Characteristics of the patient
populations are provided in Table 1.
I-123 MIBG Acquisition Protocol
Patients were instructed to abstain from medication
that could influence I-123 MIBG distribution (mainly
antihypertensive drugs and tricyclic-antidepressants).5
Prior to I-123 MIBG administration patients underwent
thyroid blocking by NaI droplets or KI capsules to
prevent thyroid uptake of free radioiodine. An average
dose of 185 MBq I-123 MIBG was slowly infused in 2
to 3 minutes. Anterior planar and SPECT images were
obtained approximately 15 minutes (early) and 4 hours
(delayed) after the injection. Anterior planar images
were acquired using a dual-detector gamma camera
(Toshiba, CGA 7200, Tokyo, Japan) equipped with a
Table 1. Population characteristics
ICD (n 5 28) NDD (n 5 11) RCT (n 5 15) P value
Age (years) 70 ± 6.1 64 ± 12.9 50 ± 10.0 \.001
Gender (% male) 20 (71%) 10 (91%) 0 \.001
Relevant medical history
Autonomic dysfunction 0 9 (81%) 0 \.001
Hypokinesia/rigidity 0 5 (45%) 1 (7%) \.001
Diabetes Mellitus 3 (11%) 2 (18%) 1 (7%) .650
Hypertension 12 (43%) 0 2 (13%) .010
Proven CAD 13 (46%) 1 (9%) 0 \.001
Infarction 17 (61%) 0 0 \.001
Heart failure 28 (100%) 0 0 \.001
Ventricular arrhythmia 18 (64%) 0 1 (7%) \.001
(Biventricular) ICD 6 (21%) 0 0 \.001
Radio/chemotherapy 0 0 15 (100%) \.001
Chi-square or ANOVA tests of the difference in distribution of various factors.
CAD, Coronary artery disease; ICD, implantable cardiac device.
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low energy high-resolution collimator (energy range up
to 170 keV). Images were collected for 10 minutes with
a 20% energy window centred on the 159 keV photo
peak. The SPECT images were acquired with similar
camera settings over 180 from right anterior oblique to
left posterior oblique. Projections were made every 4 at
35 seconds per angle using a 128 9 128 matrix (zoom
factor 1.5). SPECT data was reconstructed by ordered
subset expectation maximization with 2 iterations and
10 subsets using a Gaussian post-processing filter
(FWHM = 15 mm). No other filter or attenuation cor-
rection was applied.
Planar Image Analysis
On the early and late images ROIs were defined by
an experienced nuclear medicine technologist. The heart
ROI was manually drawn to follow the external contours
of the heart, thus including the myocardium and the left
ventricular lumen. The apices of the lung and the mid-
mediastinal line were used as anatomical landmarks for
placement of a rectangular mediastinal ROI. The mean
counts per pixel were determined in the early (e) and
delayed (d) acquisitions for each ROI and corrected for






According to the proposal for cardiac I-123 MIBG
guidelines,5 WOR is defined as;
WOR ¼






eH  eMð Þ
With time indicating the difference between the early
and delayed acquisition and T describing the physical
decay of I-123. The factor 0.5time/T in the denominator of
the delayed part of this formula is used to account for the
I-123 decay between the early and delayed acquisition.
SPECT Image Analysis
SPECT image analysis was performed on a Syngo-
MI workstation (Siemens Medical Solutions, USA). In a
mid-ventricular short axis (SA) view an ellipsoid was
placed to contain the entire heart. In the horizontal-long
axis (HLA) and vertical-long axis (VLA) views the
placement of this ellipsoid was evaluated and adjusted
when needed to enclose the base and apex. A second
ellipsoid was positioned to contain the left ventricular
lumen. Based on this information, three-dimensional
volumes of interest (VOIs) are automatically created for
the heart and lumen. The activity in the myocardial wall
was defined as ‘left ventricular counts minus lumen
counts’. A box-shaped mediastinal VOI was placed
conform the planar methodology. Uptake ratios and
WOR were determined by applying the aforementioned
formulas to three VOI combinations; HM, myocardial
wall-to-mediastinum (MM) and myocardial wall-to-
lumen (ML) regions. These values were compared to
the planar indices to determine the discriminatory value
of the SPECT indices in the patient populations.
The quantitative values determined on planar
images are prone to count changes in the adjacent
organs. To study the effects of I-123 MIBG uptake in
adjacent organs in SPECT quantification, box-shaped
VOIs were placed in centre of the liver and right lung.
All box-shaped VOIs were between 10 and 15 cm3. For
each VOI the size, uptake and washout were determined.
The organ-specific washout was defined as;




Figure 1 provides an example of a normal planar
and SPECT acquisition and Figure 2 provides an exam-
ple of a patient with low cardiac count densities.
Reliability is an important aspect when manual
segmentation is performed to assess SPECT data.
Therefore, all acquisitions were segmented twice by
the same experienced observer to evaluate the test-retest
variability. The second segmentation was performed
2 weeks after the first segmentation to reduce observer
bias. The manual SPECT-based segmentation was also
performed by a second experienced observer to allow
assessment of the inter-rater variability.
Statistical Analysis
Statistical analyses were executed using the SPSS
v16.0 software (SPSS inc. Chicago, USA). All contin-
uous variables are expressed as ‘mean ± standard
deviation’, and categorical data was expressed as fre-
quencies and/or percentages. Continues variables were
assessed for their distribution with the Shapiro-Wilk
test.
Reliability can be described by a number of
different statistical techniques. It is often considered a
multi-factorial problem that is open to interpretation and
is therefore assessed by multiple measures.14-16 In this
study, test-retest and inter-rater reliability (i.e. repro-
ducibility) were evaluated by the coefficient of variation
(CV) and the intraclass correlation coefficient.
In addition to reproducibility of the segmentation
factors like VOI size and I-123 MIBG uptake in
surrounding organs may also influence quantification
of counts within the heart. If a dependency exists
between measured counts and either the size of the VOI
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or uptake in surrounding organs, the measurements are
also considered less reliable. The relationship between
VOI size and measured counts is determined by Pearson
correlation coefficients (PCC). Stepwise multivariable
regression analysis was used to determine the effects of
I-123 MIBG uptake in the surrounding organs on the
cardiac values. Regression analysis is described by the
coefficient (B), standard error (se) and the total model fit
(R2). The global SPECT uptake ratios and WORs were
compared to the widely used planar indices. Correlations
between the planar and the SPECT values were
expressed by Pearson correlation or Spearmann’s rank
correlation, when appropriate.
RESULTS
Reproducibility of VOI Size and Count
Densities
In all acquisitions the segmentation was performed
twice to assess the test-retest reliability. Size differences
between the first and the second segmentations were
Figure 1. I-123 MIBG acquisition of a patient from the RCT population (age 64 years). This
patient has breast cancer for which she receives chemo- and radiation therapy, and has no history of
cardiac diseases. A The early planar image shows normal, intense uptake in the cardiac region
(eHM = 1.94, dHM = 2.23, WOR = 0.02). B The VOIs for the left ventricle, lumen, medias-
tinum, right lung and liver are drawn into the SPECT acquisition. Based on these VOIs indices for
the HM (eHM = 3.22, dHM = 2.97, WOR = 0.09), MM (eMM = 1.78, dMM = 1.51,
WOR = 0.32) and ML (eML = 1.24, dML = 1.04, WOR = 0.82) are determined.
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found for all VOIs, as could be expected. The repro-
ducibility of the box-shaped VOI size was considered
relatively low (ICC ranging from -0.17 to 0.03 and CV
ranging from 12.2% to 18.4%). In general, the elliptical
cardiac VOIs (i.e. heart and lumen) had high ICC values
indicating a good correlation, but also relatively high
CV values suggesting high levels of variability between
the segmentations. The size differences and the corre-
sponding ICC or CV values are provided in Table 2a.
A low reproducibility of VOI size could result in
poor reliability of the measured count densities. None-
theless, the variability in count densities derived from
the box-shaped VOIs was moderate, suggesting that the
count densities obtained by the box-shaped VOI can be
reliable. The cardiac VOIs provide highly reliable count
densities in the test-retest evaluation (see Table 2b). The
ICCs and CVs of the uptake ratios determined based on
the three VOI combinations (HM, MM and ML) are
Figure 2. I-123 MIBG acquisition of a patient from the NDD population (age 60 years). This
patient suffers from Parkinson’s disease and diabetes mellitus, but has no history of cardiac
diseases. A The early planar image shows a severely reduced accumulation of I-123 MIBG in the
cardiac region, but intense uptake in the liver and lung. (eHM = 1.21, dHM = 1.15,
WOR = 0.42). B The VOIs for the left ventricle, lumen, mediastinum, right lung and liver are
drawn into the SPECT acquisition. Based on these VOIs indices for the HM (eHM = 1.09,
dHM = 0.91, WOR = 3.75), MM (eMM = 0.41, dMM = 0.26, WOR = -0.31) and ML
(eML = 0.60, dML = 0.52, WOR = 0.08) are determined.
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provided in Table 2c. The inter-rater variability of the
count densities for the cardiac VOIs was also considered
low, as can be seen in Table 3. Both the CV and the ICC
suggest a high degree of consistency in the values
produced by the two raters. The variation among the
uptake ratios is higher, as was also demonstrated in the
test-rest analysis.
When the total population is subdivided into the
three patient groups, the test-retest ICC for the heart
counts is 0.99 for each of the groups and the ICC for the
ventricular counts VOI ranges from 0.90 to 0.98. The
inter-rater ICC for the heart counts ranges from 0.97 to
0.99 and for the ventricular lumen from 0.88 to 0.99. So,
both in the affected and near-normal populations SPECT
segmentation of the heart can be considered
reproducible.
The Effect of VOI Size on Count Densities
The results of the test-retest analysis already suggest
that there is no clear relationship between the VOI size
and the count densities. Mean VOI sizes for all mea-
surements are provided in Table 2a. When assessing the
correlation between size and counts in all segmentations,
Table 2. Test-retest reproducibility of (a) VOI size, (b) count densities and (c) uptake ratios
Mean Difference CV ICC 95% CI
(a)
Early
Liver 13.1 ± 1.3 2.52 ± 1.6 13.7 -0.14 -0.40–0.14
Lung 13.0 ± 1.3 2.32 ± 1.5 12.5 -0.09 -0.36–0.19
Mediastinum 12.7 ± 1.5 2.32 ± 1.7 18.4 0.00 -0.27–0.28
Heart 522.0 ± 237.5 77.2 ± 76.0 10.5 0.90 0.84–0.94
Lumen 10.4 ± 6.9 4.38 ± 4.7 29.8 0.65 0.46–0.78
Delayed
Liver 13.2 ± 1.3 2.27 ± 1.7 12.2 -0.13 -0.39–0.15
Lung 13.3 ± 1.3 2.58 ± 1.8 13.7 -0.17 -0.43–0.11
Mediastinum 12.7 ± 1.5 2.39 ± 1.8 13.3 0.03 -0.25–0.29
Heart 519.0 ± 232.2 83.3 ± 107.1 11.5 0.84 0.75–0.91
Lumen 10.4 ± 6.9 4.03 ± 4.4 27.6 0.70 0.52–0.81
(b)
Early
Liver 28.0 ± 7.7 4.14 ± 3.6 10.4 0.79 0.63–0.87
Lung 12.8 ± 3.6 0.94 ± 0.9 5.2 0.93 0.88–0.96
Mediastinum 4.8 ± 1.3 1.25 ± 1.0 18.4 0.47 0.20–0.66
Heart 9.3 ± 3.6 0.20 ± 0.2 1.5 0.99 0.99–1.00
Lumen 5.0 ± 1.7 0.33 ± 0.3 4.7 0.96 0.93–0.98
Delayed
Liver 26.6 ± 9.0 3.03 ± 2.5 8.1 0.91 0.81–0.95
Lung 10.5 ± 3.0 0.69 ± 0.6 4.6 0.95 0.91–0.97
Mediastinum 4.1 ± 1.0 0.50 ± 0.4 8.7 0.84 0.72–0.90
Heart 8.2 ± 4.4 0.23 ± 0.2 1.9 0.99 0.99–1.0
Lumen 4.4 ± 2.2 0.34 ± 0.3 5.4 0.97 0.95–0.99
(c)
Early
HM ratio 1.92 ± 0.4 0.48 ± 0.3 17.8 0.37 0.09–0.59
MM ratio 0.86 ± 0.3 0.25 ± 0.2 20.1 0.57 0.23–0.77
ML ratio 0.82 ± 0.2 0.13 ± 0.2 11.2 0.60 0.37–0.75
Delayed
HM ratio 1.98 ± 0.7 0.26 ± 0.2 9.4 0.90 0.82–0.95
MM ratio 0.89 ± 0.4 0.15 ± 0.1 12.0 0.89 0.81–0.93
ML ratio 0.81 ± 0.2 0.14 ± 0.1 12.5 0.61 0.40–0.76
One sample T test of the absolute differences between the two measurements, all differences were P\ .001.
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no significant correlations were found in both early and
delayed SPECT for liver (early PCC = 0.179, P = .066;
delayed PCC = -0.015, P = .876), lung (early PCC =
0.131, P = .182; delayed PCC = 0.155, P = .112),
heart (early PCC = -0.123, P = .209; delayed PCC =
-0.143, P = .144) and mediastinal VOIs (early PCC =
0.030, P = .759; delayed PCC = -0.063, P = .524).
Only for the lumen VOI moderate correlations were
found in both early and delayed segmentations (early
PCC = -0.344, P \ .001; delayed PCC = -0.227,
P = .020) suggesting a relationship between VOI size
and measured counts.
The Effect of Organ Uptake on
Quantification
The effect of I-123 MIBG uptake in the surrounding
organs was evaluated by multivariable regression anal-
ysis. The mediastinal uptake was an independent
predictor of uptake within the entire heart (early
B = 2.06, se = 0.38, R2 = 0.36; delayed B = 2.74,
se = 0.448, R2 = 0.43) and in the myocardial wall
(early B = 0.96, se = 0.22, R2 = 0.28; delayed
B = 1.27, se = 0.248, R2 = 0.37). The lung washout
was found to be an important explanatory variable of the
organ washout in the entire heart (B = 0.58, se = 0.10,
R2 = 0.38) and the myocardial wall (B = 0.69,
se = 0.14, R2 = 0.33). For both cardiac uptake and
washout, changes in liver uptake were not considered an
important factor. The luminal count densities, although
not included in the multivariate analysis, did show a
strong relation to the uptake and washout in the heart or
myocardial wall (Figure 3).
Relationship Between Planar and SPECT
Indices
The values for the planar and SPECT indices for the
three different populations are provided in Table 4, as
Table 3. Inter-rater reproducibility
Mean Difference CV ICC 95% CI
Early
Mediastinum 4.2 ± 0.9 0.73 ± 0.5 12.2 0.63 0.25–0.81
Heart 9.1 ± 3.5 0.35 ± 0.3 2.7 0.99 0.98–1.00
Lumen 4.8 ± 1.7 0.46 ± 0.3 6.7 0.94 0.89–0.97
HM ratio 2.17 ± 0.6 0.34 ± 0.3 11.0 0.80 0.57–0.90
MM ratio 1.01 ± 0.4 0.20 ± 0.2 14.0 0.77 0.58–0.87
ML ratio 0.87 ± 0.3 0.19 ± 0.1 14.9 0.52 0.29–0.69
Delayed
Mediastinum 3.9 ± 1.0 0.42 ± 0.3 13.4 0.66 0.30–0.82
Heart 8.1 ± 4.3 0.21 ± 0.2 1.8 0.99 0.99–1.00
Lumen 4.4 ± 2.2 0.74 ± 0.6 6.8 0.97 0.94–0.98
HM ratio 2.08 ± 0.9 0.43 ± 0.5 14.6 0.75 0.52–0.87
MM ratio 0.95 ± 0.5 0.23 ± 0.3 17.2 0.74 0.56–0.84
ML ratio 0.84 ± 0.2 0.20 ± 0.2 17.3 0.51 0.28–0.69












































Figure 3. A The relationship between the heart uptake and the
luminal count density on early (R2 = 0.94) and delayed
acquisition (R2 = 0.96). B The relationship between myocar-
dial uptake and the luminal count density on early (R2 = 0.79)
and delayed acquisition (R2 = 0.85).
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are the correlation between the SPECT and the planar
indices. Especially the cardiac uptake ratios determined
based on the SPECT data had a good correlation with
the planar uptake values, as can be seen in Figure 4. The
method using the ML ratio had the lowest regression
coefficients, whereas the HM and MM had a moderate-
to-good relationship with the planar indices. Using these
latter two methods, it was also possible to discriminate
between the three clinical patient populations (see
Table 4).
DISCUSSION
In this study, a simple volumetric-based segmenta-
tion of I-123 MIBG SPECT data was introduced to
determine global uptake and washout in the entire heart
and myocardial wall. Both the test-retest and the inter-
rater reproducibility of the measured cardiac count
densities were high, despite the low reproducibility of
the VOI sizes. In both the affected and the near-normal
populations SPECT segmentation of the heart can be
performed and was found to be reproducible. The
correlations between the widely used planar and SPECT
indices was high for the uptake ratios determined based
on the HM and MM regions. The differences between the
three clinical patient populations were most profound
when using the HM SPECT indices, which may suggest
that this method has the best discriminatory value.
Effects of Extra Cardiac I-123 MIBG Uptake
The extent to which external factors influence a
measurement can be just as important for the clinical
value of a technique as the reproducibility or the
discriminatory value. Verberne et al.17 demonstrated
that cardiac organ washout on planar images can be
explained by a model containing mediastinum and lung
washout. This implies that changes in myocardial count
densities overtime are, to some extent, related to count
changes in the surrounding organs.
Since cardiac segmentation can be performed more
precisely on SPECT images due to the three-dimensional
information content, it was anticipated that cardiac count
densities determined on SPECT images were less prone
to influences from surrounding organs. The results of this
study suggest that mediastinal uptake was an important
explanatory variable of cardiac uptake on both early and
delayed images. Lung washout, on the other hand, was an
independent predictor of the cardiac washout. Even
though, the inclusion of mediastinal and lung counts into
the cardiac VOI is limited when applying SPECT
segmentation; these count densities do seem to correlate
with the cardiac uptake and washout measures. Whether
these effects are caused by technical problems in the
segmentation, or reflect a true relation in the innervation
processes within these organs remains unclear.
Liver uptake or washout had a smaller impact on
quantification of cardiac counts, as was shown by both
Table 4. Relation between planar and SPECT indices
Correlations Mean values for clinical populations
PCC P value ICD NDD RCT P value
Early
Planar HM – 1.53 ± 0.3 1.44 ± 0.3 1.71 ± 0.2 .024
SPECT HM 0.795 \.001 1.95 ± 0.5 1.70 ± 0.8 2.52 ± 0.3 .001
SPECT MM 0.771 \.001 0.91 ± 0.3 0.73 ± 0.5 1.20 ± 0.2 .006
SPECT ML 0.578 \.001 0.87 ± 0.2 0.69 ± 0.3 0.93 ± 0.2 .011
Delayed
Planar HM – 1.40 ± 0.2 1.38 ± 0.4 1.75 ± 0.2 \.001
SPECT HM 0.851 \.001 1.69 ± 0.6 1.63 ± 1.1 2.54 ± 0.3 \.001
SPECT MM 0.842 \.001 0.79 ± 0.3 0.71 ± 0.5 1.22 ± 0.2 .001
SPECT ML 0.497 \.001 0.85 ± 0.2 0.74 ± 0.3 0.92 ± 0.2 .139
Washout
Planar HM – 0.49 ± 0.38 0.48 ± 0.35 0.15 ± 0.13 \.001
SPECT HM 0.706 \.001 0.41 ± 0.65 0.97 ± 1.32 0.04 ± 0.32 .002
SPECT MM 0.359 .010 -0.71 ± 2.47 0.10 ± 0.56 1.38 ± 4.30 .044
SPECT ML -0.145 .315 0.18 ± 2.06 -0.65 ± 1.90 1.56 ± 2.40 .163
HM, Heart-to-mediastinum ratio; MM, myocardial wall-to-mediastinum ratio; ML, myocardial wall-to-lumen ratio.
Pearson correlation analysis or Spearman’s rank correlation between the planar and the SPECT for uptake and washout indices.
Anova or Kruskal-Wallis analysis to determine the difference between the mean values.
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the study of Verberne et al17 and our study. Still, it is
described that liver uptake has to be reckoned with when
visually assessing I-123 MIBG SPECT images.13,18
Most often, uptake in the liver causes areas of reduced
myocardial count densities, especially in inferior wall.
In severe cases, the liver will superimpose on the
myocardial wall making the entire inferior wall non-
assessable.
Lumen, Myocardial Wall or Entire Left
Ventricle
In advance, it was hypothesized that SPECT imag-
ing could also be more suitable for global quantification
as it can distinguish between myocardial wall, ventric-
ular lumen and surrounding organs. When using separate
VOIs to describe the myocardial wall and lumen, it is
possible to use the cardiac lumen as non-specific uptake
measure which can be calibrated using a blood sample.
This methodology was previously described by Somsen
et al.19 Their study concluded that this is an accurate
method to assess myocardial I-123 MIBG uptake.
The results of our study (Figure 3) demonstrate a
strong positive relationship between the cardiac and the
lumen count densities. This correlation is most likely the
result of the spillover effect from the myocardial wall,
and probably does not reflect a true relation between
myocardial counts and the non-specific I-123 MIBG
uptake. Additionally, the gathered experience suggests
that lumen VOIs are more difficult to position than heart
VOIs, especially in patients with small heart sizes or
severely reduced cardiac uptake. These observations are
supported by the reproducibility analysis, in which
variability of lumen counts is higher than the variability
of cardiac counts. Furthermore, a moderate correlation
between the VOI size and the count densities was found
for the lumen, suggesting that lumen counts are partly
dependent on VOI size. All these findings suggest that
lumen-based quantification of non-specific uptake may
be less reliable, than for instance the mediastinal counts.
Additionally, a recent study demonstrated in planar
images that cardiac and mediastinal count densities are
unrelated to changes in vascular I-123 MIBG activity,
making a blood pool correction somewhat redundant.20
Uptake ratios as well as washout determined by the
MM or HM regions showed a good relationship with the
planar indices (Figure 4). The measurements based on
the HM regions were considered to be more reproduc-
ible than the MM measures, and had a better
discriminatory value. Still, more research has to be
performed to establish the clinical value of both of these
SPECT-based quantification methods.
Other Methods to Assess Innervation Based
on SPECT Data
The majority of the studies visually score cardiac
uptake based on either the SA, HLA and VLA views or
polarmap display.6,8,10-13,22-24 Automated evaluation or
comparisons to a normal database are possible when
polarmaps are used. All these methods rely on the basic
principle that segmental uptake is scaled to the maxi-
mum count density within the heart. However, I-123
MIBG uptake can be abnormal throughout the myocar-
dium creating a false representation of cardiac uptake.
Additionally, false positive washout defects can be
induced when discrepancies in delineation or orientation
between the early and the delayed images are present.
Figure 4. Relationships between the early and the delayed
uptake ratios of the planar and the SPECT uptake indices
determined by the four different methods. A HM (early
R2 = 0.64, delayed R2 = 0.74). B MM (early R2 = 0.60,
delayed R2 = 0.71). C ML (early R2 = 0.33, delayed
R2 = 0.25).
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Thus, it is important to relate visual or automated
scoring to count-based indices such as the HM ratio.5
At present, there are only a few studies that describe
count-based indices derived from I-123 MIBG SPECT
data. Druschky et al21 placed 33 small square ROIs in
six SA slices to assess global and regional myocardial
uptake. Results were expressed as percentage of the
maximum ROI, and were used to calculate an inhomo-
geneity index. Since counts in each ROI are scaled to the
maximum uptake, one expects that the scaling problem
can arise in patients with overall reduced I-123 MIBG
uptake. However, the idea of an inhomogeneity index is
probably more suitable to described I-123 MIBG
abnormalities in SPECT data, because there is no need
to scale the data.
Somsen et al19 used single- and multi-slice SPECT
data in which cardiac counts were related to either
lumen or organ uptake. Their findings indicate that the
single-slice SPECT method had a poor reproducibility,
making it less suitable for global quantification. The
multi-slice method, in which the entire cardiac volume
is segmented, had a high reproducibility with CVs of
\5%. The results found for the multi-slice method are
comparable to the results found in our study.
Clinical Application of I-123 MIBG SPECT
The regional assessment of cardiac innervation
using SPECT is less established than planar I-123
MIBG imaging. In general, SPECT imaging is advisable
in diseases were cardiac innervation is affected in a
heterogeneous manner. There are, at present, a few
clinical indications described for SPECT imaging which
include ischaemic heart disease, ventricular arrhythmias
and diabetes mellitus.9
The areas of sympathetic denervation often exceed
beyond that of the perfusion defects, because sympa-
thetic neurons are considered to be more sensitive to
ischaemic events than cardiac myocytes. Furthermore, it
is thought that chronic repetitive ischaemia may induce
long-term sympathetic nerve dysfunction.25 These
mechanisms also ensure that in the early stages of
coronary artery disease or during frequent vasospastic
events, sympathetic neurons can be affected without the
presence of obvious perfusion defects.11,22,26 This het-
erogenic cardiac sympathetic innervation, in otherwise
viable myocardium, is thought to be the source of
electrical instability which is associated with the devel-
opment of ventricular arrhythmias.12,27 The role of
SPECT I-123 MIBG imaging in ischaemic heart disease
and ventricular arrhythmias is therefore mainly focused
on describing the regional sympathetic innervation
status and detecting areas with perfusion/innervation
mismatch.10,28 Cardiac autonomic neuropathy (CAN) in
patients with diabetes mellitus, on the other hand, is
associated with regional hyperactivity of the sympa-
thetic nervous system, resulting in an electrical
instability.8,29 It is recognized that planar I-123 MIBG
imaging is useful to detect CAN and provide prognostic
information on future cardiac events.30-32 However,
planar indices are less sensitive in detecting small
regional abnormalities which are often associated with
diabetic neuropathy. Therefore, it was suggested by
Hattori et al8 that I-123 MIBG SPECT imaging should
be used to detect CAN. Still, the additive role of SPECT
imaging in diabetes needs to be established.
Study Limitations
In this study, a straightforward volumetric tech-
nique was introduced that is able to provide reproducible
global I-123 MIBG parameters. The initial results
indicate that it is possible to distinguish between
different patient populations using these SPECT indices,
and that these indices relate to the planar measures. Still,
this study does not provide a validation of this quanti-
tative method. Such a validation will require the
comparison of the new SPECT-based method to a
golden standard. At present, there are no measures that
can serve as a true golden standard, only the prognosis
of the patient can be used as such. The only other
imaging technique that is able to directly assess cardiac
sympathetic innervation is C-11 meta-hydroxyephedrine
(HED) positron emission tomography (PET).33 This
technique is, however, only available in a limited
number of centres and is not yet considered to be
standard clinical practice. Accordingly, more research
has to be performed to establish the value of I-123
MIBG SPECT imaging over planar imaging in specific
patient populations.
CONCLUSION
By applying a simple volumetric segmentation
method we were able determine global uptake and
washout in the entire heart or myocardial wall in all
patients. In general I-123 MIBG SPECT quantification
was found to be highly reproducible, reliable and had a
moderate-to-good correlation with the planar indices.
Still, the additive value of I-123 MIBG SPECT quan-
tification over planar imaging has to be established in
specific patient populations.
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